» Articles » PMID: 22132071

Structural Analysis of Prolyl Oligopeptidases Using Molecular Docking and Dynamics: Insights into Conformational Changes and Ligand Binding

Overview
Journal PLoS One
Date 2011 Dec 2
PMID 22132071
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Prolyl oligopeptidase (POP) is considered as an important pharmaceutical target for the treatment of numerous diseases. Despite enormous studies on various aspects of POPs structure and function still some of the questions are intriguing like conformational dynamics of the protein and interplay between ligand entry/egress. Here, we have used molecular modeling and docking based approaches to unravel questions like differences in ligand binding affinities in three POP species (porcine, human and A. thaliana). Despite high sequence and structural similarity, they possess different affinities for the ligands. Interestingly, human POP was found to be more specific, selective and incapable of binding to a few planar ligands which showed extrapolation of porcine POP in human context is more complicated. Possible routes for substrate entry and product egress were also investigated by detailed analyses of molecular dynamics (MD) simulations for the three proteins. Trajectory analysis of bound and unbound forms of three species showed differences in conformational dynamics, especially variations in β-propeller pore size, which was found to be hidden by five lysine residues present on blades one and seven. During simulation, β-propeller pore size was increased by ∼2 Å in porcine ligand-bound form which might act as a passage for smaller product movement as free energy barrier was reduced, while there were no significant changes in human and A. thaliana POPs. We also suggest that these differences in pore size could lead to fundamental differences in mode of product egress among three species. This analysis also showed some functionally important residues which can be used further for in vitro mutagenesis and inhibitor design. This study can help us in better understanding of the etiology of POPs in several neurodegenerative diseases.

Citing Articles

Post-Proline Cleaving Enzymes (PPCEs): Classification, Structure, Molecular Properties, and Applications.

Baharin A, Ting T, Goh H Plants (Basel). 2022; 11(10).

PMID: 35631755 PMC: 9147577. DOI: 10.3390/plants11101330.


Novel Insights Into Fitness Guided by Temperature Changes Along With Its Subtilisins and Oligopeptidase B.

Zabala-Penafiel A, Cysne-Finkelstein L, Conceicao-Silva F, Fagundes A, Miranda L, Souza-Silva F Front Cell Infect Microbiol. 2022; 12:805106.

PMID: 35531337 PMC: 9069558. DOI: 10.3389/fcimb.2022.805106.


First Crystal Structure of Bacterial Oligopeptidase B in an Intermediate State: The Roles of the Hinge Region Modification and Spermine.

Petrenko D, Timofeev V, Britikov V, Britikova E, Kleymenov S, Vlaskina A Biology (Basel). 2021; 10(10).

PMID: 34681120 PMC: 8533160. DOI: 10.3390/biology10101021.


Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants.

Qu Y, Zhang X, Wang M, Sun L, Jiang Y, Li C Virol Sin. 2021; 36(5):934-947.

PMID: 34224110 PMC: 8255729. DOI: 10.1007/s12250-021-00409-4.


Prolyl Oligopeptidase From : Biochemical Characterization and Involvement in Macrophage Infection.

Lasse C, Azevedo C, de Araujo C, Motta F, Andrade M, Rocha A Front Microbiol. 2020; 11:1060.

PMID: 32547514 PMC: 7271538. DOI: 10.3389/fmicb.2020.01060.


References
1.
Goossens F, De Meester I, Vanhoof G, Scharpe S . Distribution of prolyl oligopeptidase in human peripheral tissues and body fluids. Eur J Clin Chem Clin Biochem. 1996; 34(1):17-22. DOI: 10.1515/cclm.1996.34.1.17. View

2.
Morain P, ROBIN J, De Nanteuil G, Jochemsen R, Heidet V, Guez D . Pharmacodynamic and pharmacokinetic profile of S 17092, a new orally active prolyl endopeptidase inhibitor, in elderly healthy volunteers. A phase I study. Br J Clin Pharmacol. 2000; 50(4):350-9. PMC: 2014995. DOI: 10.1046/j.1365-2125.2000.00270.x. View

3.
Walter R, Shlank H, Glass J, SCHWARTZ I, Kerenyi T . Leucylglycinamide released from oxytocin by human uterine enzyme. Science. 1971; 173(3999):827-9. DOI: 10.1126/science.173.3999.827. View

4.
Eswar N, John B, Mirkovic N, Fiser A, Ilyin V, Pieper U . Tools for comparative protein structure modeling and analysis. Nucleic Acids Res. 2003; 31(13):3375-80. PMC: 168950. DOI: 10.1093/nar/gkg543. View

5.
Fulop V, Bocskei Z, Polgar L . Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysis. Cell. 1998; 94(2):161-70. DOI: 10.1016/s0092-8674(00)81416-6. View